
FDA's Call: Strategic Imperatives for Generative AI in Medical Devices
The U.S. FDA's recent move to solicit public input on generative AI in medical devices signals a pivotal moment for healthcare technology. This development demands a proactive enterprise strategy, focusing on rigorous governance and compliance frameworks. Organizations must ensure safe, effective, and ethically sound AI deployment while continuing to build innovation.







